Viz.ai, UCSF to Commercialize 3 Cardiac AI Algorithms
Viz.ai signs an exclusive licensing agreement with UCSF to commercialize 3 AI algorithms for the auto-detection of cardiovascular diseases
Stay updated with breaking news from Care Coordination Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viz.ai signs an exclusive licensing agreement with UCSF to commercialize 3 AI algorithms for the auto-detection of cardiovascular diseases
Last week, the FDA authorized marketing for Viz.AI’s Viz HCM, a standalone ECG analysis software to identify adult patients for further follow-up for hypertrophic cardiomyopathy.
Viz.ai, a San Francisco-based AI-powered disease detection and care coordination platform raises $1000M in Series D funding
Jacksonville, FL (PRWEB) August 17, 2021 -- Forcura, a healthcare technology company that enables safer patient care transitions and coordination, today